SMS Pharmaceuticals has informed that it enclosed the press release titled ‘SMS Pharmaceutical’s Associate Company, VKT Pharma, receives US FDA approval for its reformulated Ranitidine’. The above information will also be made available on the website of the Company at www.smspharma.com.
The above information is a part of company’s filings submitted to BSE.